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Global phylogenetic analysis of 
Escherichia coli and plasmids 
carrying the mcr-1 gene indicates 
bacterial diversity but plasmid 
restriction
Sébastien Matamoros  1, Jarne M. van Hattem1, Maris S. Arcilla2, Niels Willemse1, Damian 
C. Melles2, John Penders3,4, Trung Nguyen Vinh1,5,6, Ngo Thi Hoa6,7 , COMBAT consortium*, 
Menno D. de Jong1& Constance Schultsz1,5
To understand the dynamics behind the worldwide spread of the mcr-1 gene, we determined the 
population structure of Escherichia coli and of mobile genetic elements (MGEs) carrying the mcr-1 gene. 
After a systematic review of the literature we included 65 E. coli whole genome sequences (WGS), 
adding 6 recently sequenced travel related isolates, and 312 MLST profiles. We included 219 MGEs 
described in 7 Enterobacteriaceae species isolated from human, animal and environmental samples. 
Despite a high overall diversity, 2 lineages were observed in the E. coli population that may function 
as reservoirs of the mcr-1 gene, the largest of which was linked to ST10, a sequence type known for its 
ubiquity in human faecal samples and in food samples. No genotypic clustering by geographical origin 
or isolation source was observed. Amongst a total of 13 plasmid incompatibility types, the IncI2, IncX4 
and IncHI2 plasmids accounted for more than 90% of MGEs carrying the mcr-1 gene. We observed 
significant geographical clustering with regional spread of IncHI2 plasmids in Europe and IncI2 in Asia. 
These findings point towards promiscuous spread of the mcr-1 gene by efficient horizontal gene transfer 
dominated by a limited number of plasmid incompatibility types.
Antimicrobial resistance (AMR) represents a growing threat to global health1. With barely any new antimicrobial 
drugs in development2, limiting the spread of AMR is key in order to maintain current treatment options3.
Colistin is an antibiotic of the polymyxin class, discovered in 1950 and effective against Gram-negative bacte-
ria4. The emergence of multidrug-resistant Gram-negative bacteria, especially those producing carbapenemases, 
has reintroduced colistin as a last resort antibiotic for the treatment of severe infections5. In contrast to its limited 
use in humans, colistin is widely used in food-producing animals6. While colistin resistance was long thought 
to be caused by chromosomal mutations only7, the emergence of plasmid-mediated resistance, conferred by the 
mobilized colistin resistance (mcr-1) gene, was recently reported8. This gene encodes for a protein of the phos-
phoethanolamine transferase enzyme family, and its expression results in the addition of a phosphoethanolamine 
to lipid A, the target of colistin, decreasing the interaction between colistin and the bacterial lipopolysaccharide8. 
Since its discovery in 2015 in China, this gene has been described in several bacterial species that were isolated 
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from animals, animal food products, humans and environmental samples from around the world9–13. Our pre-
vious study in travellers indicated acquisition of mcr-1 carrying bacteria by healthy individuals during travel to 
destinations around the world, potentially related to food exposure, as well as rapid clearance after return14. It 
has been suggested that mcr-1 has spread from food animals to humans8,15–17, but there is a lack of comparison of 
mcr-1 carrying isolates on a global level to support this hypothesis.
We studied the global population structure as well as the geographic and host distribution of mcr-1-carrying 
Escherichia coli, and mobile genetic elements (MGEs), to establish the population structure and to assess whether 
the spread of the mcr-1 gene is linked to clonal dissemination or transmission of MGEs from animal, human, or 
environmental sources within geographic regions.
Results
Literature search. A systematic review of the literature on mcr-1, published until 1 January 2017 resulted 
in the inclusion of 95 articles, representing a total of 410 entries (whole genome sequences, MLST profiles, and/
or plasmid types) for analysis (See detailed methods and results in Supplementary data, Supplementary Figure 1 
and Supplementary Table 1).
Population structure. Whole genome sequencing (WGS). The genomes of 65 mcr-1-carrying E. coli were 
analysed, including 6 genomes from E. coli isolated from travellers that were sequenced for the purpose of the 
present study. Isolates originated from Asia (n = 36; 55.4%), Europe (n = 20; 30.8%), North-America (n = 4; 
6.2%), South-America (n = 4; 6.2%) and Africa (n = 1; 1.5%). 45 were of animal origin (69.2%), 19 of human 
origin (29.2%) and one strain (1.5%) was isolated from water (Supplementary Table 1).
The average size of the genomes (all contigs in each assembly, representing chromosomes and plasmids) of 
these 65 isolates was 4.9 Mbp, with a median number of genes identified of 4785 (ranging from 4266 to 7083), rep-
resenting a pangenome of 23248 genes and a core genome (defined by genes present in at least 99% of the isolates) 
of 2216 genes. An unbiased analysis of the population structure was performed using a Bayesian approach with 
the BAPS software18, based on the nucleotide alignment of the core genome sequences. It revealed the presence 
of 5 distinct phylogenetic clusters (Fig. 1; Supplementary Figure 2; Supplementary Table 1). The largest cluster 
(cluster 1) consisted of 26 isolates from 16 different STs (26/65; 40.0%) and the second cluster consisted of 24 
isolates from 15 different STs (36.9%). No significant relationship between clustering (BAPS) and geographical 
origin or isolation source was observed (χ2-test) (Fig. 1) except that all 5 isolates that belong to BAPS cluster 3 
are from Europe. Twenty isolates showed less than 10 SNPs/Mbp difference with at least 1 other isolate and were 
considered clonally related (Supplementary Tables 2 and 3).
Multilocus sequence typing (MLST). For 312 E. coli isolates originating from 69 studies, a MLST profile was 
published or could be deduced from the corresponding WGS. Of these, 206 were isolated from animals or animal 
products (66.0%), 101 were isolated from humans (32.4%), including the 6 travel acquired isolates, and 5 from the 
Figure 1. Maximum-likelihood tree based on concatenated core genome sequences of 65 mcr-1-carrying  
E. coli isolates. Branch colours indicate phylogenetic clusters as determined by BAPS. Isolates from ST10, ST165 
and closely related isolates are all grouped in the BAPS cluster 2 (dark blue). Leaf (isolates identifiers) colours 
indicate geographical region of origin. Isolation source is indicated in brackets: A = animal or meat; H = human; 
E = environment. The 6 travellers’ isolates that were sequenced for this study are highlighted in bold and names 
start with CBT. Tree scale in number of substitutions per site. *Number of isolates.
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environment (1.6%). 141 Isolates from 25 studies (141/312; 45.2%) originated from Asia and 125 isolates from 25 
studies (40.1%) from Europe, together accounting for 85.3% of all included isolates. The isolates represented 112 
unique sequence types (STs) with ST10 being most common, comprising 40/312 (12.8%) isolates originating from 
Africa, Asia, Europe and South-America.
eBURST analysis19 was performed on all isolates included in the study, to identify their genetic relatedness 
based on their MLST profiles. Three main clusters were identified, for which the predicted founders, i.e. the ST 
in a cluster from which all other SLVs and DLVs in the cluster have most likely diversified19, were ST10, ST1114 
and ST410. The largest cluster contained all 40 ST10 isolates and an additional 46 isolates in 21 STs that were 
single (SLV) or double locus variants (DLV) of ST10 (86/312; 27.6%) (Supplementary Figure 3). The predicted 
founder of the second largest cluster was ST1114, a SLV of ST165 and ST100, and included 19 isolates belonging 
to 7 different STs (5.4%), while the third cluster was centred on ST410 and included 14 isolates from 3 different 
STs (4.5%).
A maximum-likelihood tree based on concatenated MLST gene sequences showed a main clade of 128 isolates 
(represented by blue branches in Fig. 2 and Supplementary Figure 4; bootstrap value of the main branch = 0.98), 
including most, but not all, isolates from the eBURST clusters of ST10 and ST1114 (Supplementary Figure 4A). 
All isolates from these 2 eBURST clusters for which a WGS was available were grouped in BAPS cluster 2. 
Similarly, all the isolates from the eBURST cluster ST410 grouped into BAPS cluster 1, along with 6 isolates 
from ST155. Seven isolates belonged to the globally successful extra-intestinal pathogenic E. coli clone ST131 
(Supplementary Figure 4A).
As observed in the WGS analysis, animal isolates were interspersed with isolates from humans and the envi-
ronment throughout the tree, as were isolates from different continents indicating a lack of clustering by iso-
lation source or geographical origin (Fig. 2). Similarly, no clustering by health status of the host was observed 
(Supplementary Figure 4B).
Mobile genetic elements. The plasmid incompatibility group of the mcr-1-carrying plasmids could be 
determined for 217 Enterobacteriaceae isolates from 7 different species (Escherichia sp., Salmonella sp., Klebsiella 
sp., Cronobacter sp., Enterobacter sp., Kluyvera sp. and Shigella sp.), representing a total of 219 plasmids since 2 
isolates carried 2 different plasmids (Table 1). These plasmids were described in 71 studies (1 to 33 plasmids per 
study, average = 3.1). In addition, the gene was integrated in the chromosome of 6 isolates. The incompatibility 
Figure 2. Phylogeny of the mcr-1-carrying E. coli isolates. Maximum-likelihood tree based on concatenated 
MLST gene sequences, mid-point rooted. Inner coloured circle: isolation source; outer circle: region of origin. 
Stars indicate the isolates from which a whole genome sequence was available. The 6 travellers’ isolates that 
were sequenced for this study are highlighted in green. Bootstrap values between 0.9 and 1 are indicated by 
red triangles (size proportional to bootstrap value). The blue branches represent the main clade of 128 isolates 
including most isolates from ST10. Tree scale in number of substitutions per site. See Supplementary Figure 4A 
for additional information on the relationship between STs, eBURST clustering and WGS BAPS clustering.
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group could not be determined for 27 of the 65 isolates for which WGS was available. Similarly the plasmid type 
was not available for 182 of the 312 isolates included in the MLST analysis. A total of 14 different plasmid incom-
patibility groups were identified. 198/219 (90.4%) of the identified plasmids belonged to one of 3 incompatibility 
groups: IncX4 (77/219 plasmids, 35.2%), IncI2 (76/219 plasmids, 34.7%) and IncHI2 (45/219 plasmids, 20.5%). 
50/76 IncI2 plasmids (65.8%) originated from Asia and 33/45 IncHI2 plasmids (73.3%) from Europe. IncX4 
plasmids were more evenly distributed: 44/77 (57.1%) were recovered from Europe, 29 from Asia (37.7%) and 4 
from other regions (5.2%). Observed proportions were significantly different from expected for IncI2 (χ2-test, 
p < 0.001) and IncHI2 (p < 0.001) but not for IncX4. The distribution of these 3 plasmid types was not signifi-
cantly different from expected between animal (χ2-test, p = 0.24), human (p = 0.88) and environmental sources 
(p = 0.38). Isolates from the BAPS groups 1 and 2 carried plasmids from the 3 major types in similar proportions 
(Supplementary Figure 5A; Supplementary Table 1). Isolates from the eBURST clusters of ST10 carried plasmids 
belonging to 7 different incompatibility groups, including IncHI2, IncI2 and IncX4. No clustering of plasmid type 
with MLST phylogeny was observed either (Supplementary Figure 5B; Supplementary Table 1).
Figure 3 shows the alignment of the complete sequences or contigs from IncI2 (panel A), IncX4 (B) and 
IncHI2 (C) incompatibility group plasmids. IncHI2 plasmids had the largest size, with sequence lengths up to 
267486 bp.
The ISApl1 transposon element situated upstream of the mcr-1 gene was present in 7/9 (77.8%) IncHI2 plas-
mids, but only in 11/29 (37.9%) of IncI2 plasmids and completely missing in all of the 24 reported IncX4 plasmids 
(Fig. 3). In the isolates from travellers the ISApl1 transposon was identified in 3 out of our 6 mcr-1-carrying 
contigs including one isolate from a traveler to Asia (ST101, IncI2 incompatibility group), one to Africa (ST744, 
IncHI2) and one to South-America (ST744, incompatibility group not identified).
Antimicrobial resistance genes. All sequences of the mcr-1 gene collected in the present study were 100% 
identical to the original sequence described by Liu et al.8.
Multiple resistance genes were detected in most of the studied isolates (Supplementary Results). The florfen-
icol resistance gene floR was present in 32 (49.2%) isolates; in 22 of 45 isolates from animals (48.9%) and 10 of 
19 isolates from humans (52.6%). The baeR and baeS genes, encoding novobiocin resistance, were found in 64 
(98.5%) and 65 (100%) isolates, respectively.
Plasmid analysis from the WGS data showed that 4 of the 29 mcr-1-carrying IncI2 plasmids (13.8%) contained 
an additional ESBL gene. IncHI2 plasmids (n = 9) carried between 0 and 12 additional AMR genes. In particular, 
4 plasmids carried CTX-M ESBL genes and 2 carried the floR gene. In 4 out of the 9 IncHI2 plasmids analysed in 
this study, the mcr-1 gene was shown to be integrated alongside a large multi-drug resistance (MDR) gene cassette 
(Fig. 3C). None of the IncX4 plasmids carried additional AMR genes.
Discussion
Analysis of all reported WGS of mcr-1-carrying isolates shows that the population of E. coli is highly diverse, 
but is dominated by 2 large groups of related isolates. Most of the isolates from BAPS group 2 grouped into a 
MLST cluster centred on ST10. An overrepresentation of isolates related to ST10 and ST165 (a SLV of ST1114) 
in mcr-1-carrying E. coli isolates was previously reported at a smaller scale in isolates from European farm ani-
mals20. E. coli ST10 and closely related STs are frequently recovered from food and human intestinal samples and 
studies have shown a higher prevalence of plasmid-carried AMR genes in ST10, including CTX-M ESBL genes, 
compared to other STs21–24.
The other BAPS group of interest in our study (group 1) included isolates belonging to ST155. This ST has 
been described as a major vector of spread of ESBL genes from animals to humans25. It is thus possible that 
zoonotic transmission leads to the spread of the mcr-1 gene, as has been suggested in studies from China and 
Vietnam16,17, notably through the 2 main phylogenetic clusters identified in this study.
Additionally, we found clonally related isolates, including some belonging to ST744, a SLV of ST10, carry-
ing the mcr-1 gene on different plasmid backbones and recovered from different continents (see Supplementary 
Results). These results point towards a worldwide dissemination of mcr-1 driven mainly by highly promiscuous 
plasmids rather than the worldwide spread of one or more mcr-1-carrying clones. We hypothesize that several 
populations of E. coli isolates, notably those related to ST10 or ST155, acquired the mcr-1 gene due to their 
intrinsic ability of acquiring AMR genes and their high prevalence in humans and food animals. These popu-
lations of commensal isolates then may play a crucial role as a reservoir for this gene, which can explain their 
over-representation in the present study.
IncF IncFI IncFIB IncFII IncHI1
IncHI1A/ 
IncHI1B/ 
IncFIA IncHI2 IncI2
IncI2/ 
IncX4 IncP
IncX3/ 
IncX4 IncX4 IncY
repB 
(p0111)
Total 
plasmids Chromosome
Africa 0 0 1 0 0 0 4 8 0 0 0 1 0 0 14 6.4% 0
Asia 1 3 0 0 0 2 7 50 0 1 1 29 2 0 96 43.8% 2
Europe 0 0 2 1 1 0 33 5 0 3 0 44 0 1 90 41.1% 4
North-America 1 0 0 0 0 0 1 4 0 0 0 1 0 0 7 3.2% 0
Oceania 0 0 0 0 0 0 0 2 0 0 0 0 0 0 2 0.9% 0
South-America 0 0 0 0 0 0 0 7 1 0 0 2 0 0 10 4.6% 0
Total (% of total) 2 (0.9) 3 (1.4) 3 (1.4) 1 (0.5) 1 (0.5) 2 (0.9) 45 (20.5) 76 (34.7) 1 (0.5) 4 (1.8) 1 (0.5) 77 (35.2) 2 (0.9) 1 (0.5) 219 (100) 100.0% 6
Table 1. Incompatibility types of mcr-1 carrying plasmids and distribution by geographical regions.
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Figure 3. Alignment of mcr-1-containing plasmids and contigs. Panel A: IncI2 plasmids (n = 29); panel B: 
IncX4 (n = 24); panel C: IncHI2 (n = 9). Black outer ring: plasmid used as reference for the alignment; name 
and size of the reference indicated in the middle of each panel. Plasmid names followed by “_mcr1_contig” 
refer to assembled contigs from whole genome sequences. Other names refer to plasmid sequences deposited 
in online databases. The mcr-1 gene and ISA-pl1 location are underlined in red. Plasmids indicated with an 
asterisk are from the 6 travellers’ isolates that were sequenced for this study. Panel C: Putative MDR cassette is 
highlighted in orange.
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In the timeframe of our literature search, 3 E. coli strains carrying the mcr-2 gene were isolated from animals in 
Belgium. These isolates belonged to ST10 (2 isolates) and ST167 which is a SLV of ST10 and carried the gene on an 
IncX4-type plasmid. No WGS data was available from these isolates26. More data about the mcr-2 gene is needed 
to assess its spread and determine if E. coli ST10 plays a similar role in its dissemination as it does for mcr-1.
More than 90% of published plasmid types carrying mcr-1 genes belonged to either IncI2, IncX4 or IncHI2. Almost 
75% of the isolates carrying an IncHI2 plasmid originated from Europe: 26 from animals and 7 from humans (Table 1 
and Supplementary Table 1). In a traveller’s isolate acquired in Tunisia, the mcr-1-carrying plasmid was identified as 
an IncHI2-type backbone of the ST4 pMLST subtype which co-carried a CTX-M-1 ESBL gene (Fig. 3C). This traveller 
reported consumption of beef, chicken and eggs during travel to Tunisia which can potentially be the source for the 
acquisition of the mcr-1 positive isolate. When investigating the presence of the mcr-1 gene in cephalosporin resistant 
E. coli isolates from chicken farms in Tunisia, Grami et al.27 found that all mcr-1-carrying plasmids from their study 
(n = 37) also belonged to the IncHI2-type, ST4 subtype and harboured CTX-M-1 genes. PFGE typing of the isolates 
harbouring this plasmid showed various bacterial genetic backgrounds. Interestingly, these chickens were all imported 
from France, either as adults or chicks. Other studies showed the presence of this IncHI2, CTX-M-1 and mcr-1 com-
bination in Salmonella enterica Typhimurium isolates from meat samples in Portugal from 201128,29 and diarrhoeic 
veal calves in France30. The IncHI2 subtype ST4 was also detected in an E. coli isolate from retail chicken breast in 
Germany31 and the faecal sample of a veal calve from the Netherlands32, suggesting widespread dissemination of this 
particular plasmid in European farm animals and possible transmission to humans.
The high prevalence of novobiocin baeR and baeS and florfenicol floR resistance genes33,34 in the genomes 
of isolates of human and animal origin together with the fact that florfenicol and novobiocin are used almost 
exclusively in veterinary medicine further supports the potential role of food animals as an important reservoir 
of mcr-1 containing bacteria and MGEs15.
In contrast with the IncHI2 plasmids, 65.8% of all IncI2 plasmids recovered so far originated from Asia, with a 
much lower prevalence in mcr-1 carrying Enterobacteriaceae from other regions. Taken together, these elements 
point toward a more regional circulation and dissemination of the mcr-1-carrying plasmids IncI2 and IncHI2.
We found the ISApl1 transposon element associated with the mcr-1 gene, as originally described by Liu et al.8 
to be present in a minority of studied plasmids and contigs. However, since some of the mcr-1-carrying contigs 
were obtained by assembly of Illumina short reads from WGS data, we cannot exclude that some of these gaps are 
explained by an incomplete assembly of (plasmid) sequences. The ISApl1 transposon element is considered to be 
the main driver of horizontal gene transfer of the mcr-1 gene and has been shown to be highly unstable in IncI2 
plasmids35–37. The absence of the ISApl1 transposon element in mcr-1-carrying IncX4 plasmids as described here 
has recently been proposed to be essential for the maintenance of the mcr-1 gene in this particular backbone, but 
the exact mechanism still requires further investigation38.
WGS analysis provided in-depth information about the mcr-1-carrying E. coli isolates and their phylogenetic 
relationship, but the number of available genomes was limited. On the other hand, whilst MLST data have a lower 
resolution, the higher number of available profiles allowed analysis of the isolates’ origin (geographical, source of 
isolation, diseased status of the host, etc.).
A limitation of our study is the potential for bias. The overrepresentation of isolates originating from Asia and 
Europe could be explained by a higher prevalence of mcr-1 genes on these continents, but the effect of publica-
tion bias cannot be excluded. Isolates from North-America only represented 2.2% of the collection. Noteworthy, 
colistin, except for ophthalmic ointment, has never been marketed for use in animals in the United States39,40.
Sampling bias should also be considered when several isolates with an identical ST are presented from a single 
study, as is the case for ST100 and ST752. Additionally, in the absence of a control population of mcr-1-negative 
isolates obtained from similar sources as the mcr-1 positive isolates, results of analysis of population structures 
should be interpreted with caution. Because many studies screened existing collections of (resistant) isolates for 
colistin resistance or presence of mcr-1, selection bias has probably been introduced.
The findings in this study suggests that the mcr-1 gene has locally and globally disseminated through MGEs 
that are mainly IncHI2, IncI2 and IncX4 plasmids and provides additional support for the hypothesis of the 
animal reservoir, that is driven by the use of colistin in livestock, as a source of mcr-1 in humans. A global ban of 
colistin use in animals to preserve colistin for use in human medicine seems therefore justified.
Material and Methods
Selection of isolates for whole genome sequencing. We subjected 6 mcr-1 positive isolates that were 
collected as part of a prospective study (COMBAT study) aimed at studying acquisition of extended-spectrum 
β-lactamase (ESBL) -producing Enterobacteriaceae during travel to whole-genome sequencing14,41. Additionally, 
we included 22 whole genome sequences of isolates from Vietnamese chickens and humans that were still unpub-
lished when performing our literature search17.
Literature search. Relevant papers that published on mcr-1 and mcr-2 were identified in PubMed, Web of 
Science, Scopus, ScienceDirect and Google Scholar using the query ‘mcr-1 OR mcr1 OR mcr-2 OR mcr2 OR 
(mcr AND colistin)’ (see Supplementary Material for full search strategies). To be able to study the associations 
between phylogeny, geographic distribution and isolation source we only included sequences from papers that 
provided sufficient metadata. As a consequence, plasmids and genomes sequences that were deposited in online 
databases without metadata were not included in the analysis.
Whole genome sequencing of mcr-1-positive E. coli isolates. Bacterial DNA was extracted from 
fresh pure cultures using the Qiagen DNeasy Blood and Tissue kit (Qiagen, Hilden, Germany). Library prepa-
ration was done according to manufacturer’s instruction (Illumina, San Diego, CA, USA) and sequenced using 
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Illumina MiSeq technology with 150nt paired-end settings. Sequences have been deposited in the European 
Nucleotide Archive under the accession numbers SAME104030441 to SAME104030446.
Bio-informatic analysis. MLST analysis. For each mcr-1-carrying E. coli isolate for which the ST or the 
whole genome sequence was available, the sequences of the corresponding alleles were downloaded from the 
E. coli MLST genes repository of the University of Warwick (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli/handlers/
getFileData/home/cbailster/mlst/zope/Extensions/gadfly/Ecoli/DB/) and concatenated. When STs of isolates were 
not described in literature, the ST was determined from available whole genomes using the online service provided 
by the Center for Genomic Epidemiology (https://cge.cbs.dtu.dk/services/MLST/) according to the Achtman 
MLST scheme42,43. MLST clusters (STs and their single locus or double locus variants) were defined using e-burst 
V3 (http://eburst.mlst.net/v3/enter_data/single/)19 and goeBURST v1.2.144 using only profiles from this study.
WGS and plasmid analysis. Raw sequence reads in fastq format or pre-assembled sequences in fasta format were 
downloaded from online databases for all available isolates (Supplementary Table 1). Additional sequences not yet 
deposited in online databases were requested from their respective authors. The quality of the raw sequence reads 
was checked using fastqc (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/), quast45 and KmerFinder 
2.0 (https://cge.cbs.dtu.dk/services/KmerFinder/) (see Supplementary Methods for more details). Reads were 
trimmed using Trimmomatic V0.3346. De-novo genome assembly was performed with SPAdes 3.947 for Illumina 
short reads and with Canu v1.3 for PacBio long reads48. Contigs of less than 500 bp long were removed from the 
genomes to improve the overall quality of the assembly. Size of the genomes was calculated by adding the length of 
all remaining contigs. Identification of open reading frames (ORFs) and gene contents in the assembled genomes 
(de-novo assemblies and pre-assembled sequences) was performed using Prokka v1.1149. Core genome analysis 
was performed with Roary v3.6.850. Clustering of isolates was performed using the hierBAPS module of the 
Bayesian Analysis of Population Structure (BAPS) software v6.018. The core genome alignment output provided 
by Roary was used as input for BAPS with 2 levels of hierarchy and a maximum number of cluster (K) of 10. The 
estimated number of clusters was 5 for both levels of hierarchy.
Sequences (concatenated MLST loci or concatenated core genes) were aligned using mafft v6.864b51. The 
resulting alignment was used as input for calculation of distances and tree building using RAxML v8.1.652. MLST 
and WGS trees were visualized using iTOL v3.3.1 (http://itol.embl.de/)53.
Identification of plasmid incompatibility group and typing of IncHI2 plasmids were performed on assembled 
sequences (de-novo or pre-assembled) via the CGE online services PlasmidFinder v1.3 (https://cge.cbs.dtu.dk/
services/PlasmidFinder/) and pMLST v1.4 (https://cge.cbs.dtu.dk/services/pMLST/)54. Alignment and visuali-
zation of plasmids was performed with BRIG v0.9555. The majority of the isolates and plasmids described in this 
study were sequenced using a short read technology (Illumina). This technology does not allow for a high quality 
assembly of the plasmids due to the high number of repeat regions present in these MGEs. Therefore no phyloge-
netic analysis of the mcr-1-carrying plasmids was conducted in this study.
Two different databases were used for identification of other antibiotic resistance genes: ResFinder (https://
cge.cbs.dtu.dk/services/ResFinder/56) was used to detect acquired resistance genes commonly located on mobile 
genetic elements (MGEs) and CARD Resistance Gene Identifier (https://card.mcmaster.ca/analyze/rgi57) was 
used to detect chromosomal genes.
Statistics. The distribution of isolates and plasmids from different geographical origins and isolation sources was 
determined by a χ2-test comparing the expected distribution (proportions of the total studied population) to the 
observed proportions using GraphPad Prism6 (La Jolla, CA, USA).
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